Fig. 2.
Fig. 2. OS and EFS rates from diagnosis. / (A) OS and (B) EFS from diagnosis comparing group 1 (daunorubicin), group 2A (idarubicin, 10 mg/m2), and group 2B (idarubicin, 12 mg/m2).

OS and EFS rates from diagnosis.

(A) OS and (B) EFS from diagnosis comparing group 1 (daunorubicin), group 2A (idarubicin, 10 mg/m2), and group 2B (idarubicin, 12 mg/m2).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal